BJDX
Bluejay Diagnostics IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$1.99M
P/E Ratio
—
EPS
$-3.74
Beta
0.72
52W High
$16.68
52W Low
$1.62
50-Day MA
$1.89
200-Day MA
$4.31
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Bluejay Diagnostics Inc
Bluejay Diagnostics Inc. is an innovative medical technology firm focused on advancing patient care through cutting-edge diagnostic solutions aimed at early disease detection. Leveraging a proprietary platform that combines artificial intelligence with point-of-care testing, the company enhances diagnostic accuracy and speed, providing healthcare professionals with timely and actionable insights. With a robust commitment to research and development, Bluejay is adeptly positioned to fill significant healthcare gaps and cater to the growing demand for trustworthy and innovative diagnostic tools in a rapidly changing medical landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 48,910 |
| EBITDA | $-6.88M |
| Operating Margin | 0.00% |
| Return on Equity | -171.60% |
| Return on Assets | -80.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.04 |
| Price-to-Book | 0.47 |
| Price-to-Sales (TTM) | 54.99 |
| EV/Revenue | 5.67 |
| EV/EBITDA | -0.10 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.03M |
| Float | 844,450 |
| % Insiders | 11.22% |
| % Institutions | 10.62% |
Historical Volatility
HV 10-Day
60.67%
HV 20-Day
62.20%
HV 30-Day
58.77%
HV 60-Day
61.82%
HV Rank
—
Volatility is currently expanding
More HEALTHCARE Stocks
Data last updated: 5/25/2026